Dr Evatt anticipated that a public meeting to be held at the instigation of the CDC would be a "pro forma stamp for action, that is, review the data, accept the evidence as significantly supporting the case for blood-borne infection and produce recommendations that high-risk groups be excluded from the donor pool and/or adopt a surrogate test."
Chronology Information
Date:
Chapter/issue
Pharmaceutical Companies
Key Person(s)
Dr Bruce L Evatt